John F. Kadow

3.5k total citations
110 papers, 2.2k citations indexed

About

John F. Kadow is a scholar working on Organic Chemistry, Infectious Diseases and Virology. According to data from OpenAlex, John F. Kadow has authored 110 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Organic Chemistry, 42 papers in Infectious Diseases and 33 papers in Virology. Recurrent topics in John F. Kadow's work include HIV/AIDS drug development and treatment (42 papers), HIV Research and Treatment (33 papers) and Cancer Treatment and Pharmacology (25 papers). John F. Kadow is often cited by papers focused on HIV/AIDS drug development and treatment (42 papers), HIV Research and Treatment (33 papers) and Cancer Treatment and Pharmacology (25 papers). John F. Kadow collaborates with scholars based in United States, Germany and India. John F. Kadow's co-authors include Nicholas A. Meanwell, Tao Wang, Dolatrai M. Vyas, Zhongxing Zhang, David R. Langley, Zhong Yang, Byron H. Long, Zhiwei Yin, William C. Rose and Craig R. Fairchild and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Virology and Journal of Medicinal Chemistry.

In The Last Decade

John F. Kadow

108 papers receiving 2.1k citations

Peers

John F. Kadow
Vincent J. Kalish United States
Brian M. McKeever United States
M. Arshad Siddiqui United States
Naoyuki Kanzaki Japan
Cristina Tintori Italy
V. L. Narayanan United States
Marco Radi Italy
Paul A. Aristoff United States
Antonio Coluccia Italy
Robert Zahler United States
Vincent J. Kalish United States
John F. Kadow
Citations per year, relative to John F. Kadow John F. Kadow (= 1×) peers Vincent J. Kalish

Countries citing papers authored by John F. Kadow

Since Specialization
Citations

This map shows the geographic impact of John F. Kadow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John F. Kadow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John F. Kadow more than expected).

Fields of papers citing papers by John F. Kadow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John F. Kadow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John F. Kadow. The network helps show where John F. Kadow may publish in the future.

Co-authorship network of co-authors of John F. Kadow

This figure shows the co-authorship network connecting the top 25 collaborators of John F. Kadow. A scholar is included among the top collaborators of John F. Kadow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John F. Kadow. John F. Kadow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Subbaiah, Murugaiah A. M., Sarmistha Halder Sinha, Sandhya Mandlekar, et al.. (2022). Improving Drug Delivery While Tailoring Prodrug Activation to Modulate Cmax and Cmin by Optimization of (Carbonyl)oxyalkyl Linker-Based Prodrugs of Atazanavir. Journal of Medicinal Chemistry. 65(16). 11150–11176. 2 indexed citations
2.
Wang, Tao, John F. Kadow, Nicholas A. Meanwell, & Mark Krystal. (2022). The Genesis and Future Prospects of Small Molecule HIV-1 Attachment Inhibitors. Advances in experimental medicine and biology. 1366. 45–64. 2 indexed citations
3.
Subbaiah, Murugaiah A. M., Sarmistha Halder Sinha, Sandhya Mandlekar, et al.. (2020). (Carbonyl)oxyalkyl linker-based amino acid prodrugs of the HIV-1 protease inhibitor atazanavir that enhance oral bioavailability and plasma trough concentration. European Journal of Medicinal Chemistry. 207. 112749–112749. 5 indexed citations
4.
Subbaiah, Murugaiah A. M., Nicholas A. Meanwell, John F. Kadow, et al.. (2018). Coupling of an Acyl Migration Prodrug Strategy with Bio-activation To Improve Oral Delivery of the HIV-1 Protease Inhibitor Atazanavir. Journal of Medicinal Chemistry. 61(9). 4176–4188. 13 indexed citations
5.
Subbaiah, Murugaiah A. M., Nicholas A. Meanwell, & John F. Kadow. (2017). Design strategies in the prodrugs of HIV-1 protease inhibitors to improve the pharmaceutical properties. European Journal of Medicinal Chemistry. 139. 865–883. 27 indexed citations
6.
Zhuo, Xianlu, Yuefeng Wang, John E. Leet, et al.. (2016). Phosphocholine Conjugation: An Unexpected In Vivo Conjugation Pathway Associated with Hepatitis C NS5B Inhibitors Featuring A Bicyclo[1.1.1]Pentane. Drug Metabolism and Disposition. 44(8). 1332–1340. 4 indexed citations
7.
Yeung, Kap‐Sun, Zhilei Qiu, Zheng Yang, et al.. (2012). Inhibitors of HIV-1 attachment. Part 9: An assessment of oral prodrug approaches to improve the plasma exposure of a tetrazole-containing derivative. Bioorganic & Medicinal Chemistry Letters. 23(1). 209–212. 35 indexed citations
8.
Wang, Tao, Zhong Yang, Zhongxing Zhang, et al.. (2012). Inhibitors of HIV-1 attachment. Part 10. The discovery and structure–activity relationships of 4-azaindole cores. Bioorganic & Medicinal Chemistry Letters. 23(1). 213–217. 29 indexed citations
9.
Qiu, Zhilei, Haiquan Fang, Zheng Yang, et al.. (2012). Inhibitors of HIV-1 attachment. Part 7: Indole-7-carboxamides as potent and orally bioavailable antiviral agents. Bioorganic & Medicinal Chemistry Letters. 23(1). 198–202. 46 indexed citations
10.
Ding, Min, Feng He, Thomas W. Hudyma, et al.. (2012). Synthesis and SAR studies of novel heteroaryl fused tetracyclic indole-diamide compounds: Potent allosteric inhibitors of the hepatitis C virus NS5B polymerase. Bioorganic & Medicinal Chemistry Letters. 22(8). 2866–2871. 15 indexed citations
11.
Gentles, Robert G., Min Ding, Xiaofan Zheng, et al.. (2011). SAR studies on a series of N-benzyl-4-heteroaryl-1-(phenylsulfonyl)piperazine-2-carboxamides: Potent inhibitors of the polymerase enzyme (NS5B) of the hepatitis C virus. Bioorganic & Medicinal Chemistry Letters. 21(10). 3142–3147. 5 indexed citations
12.
Gentles, Robert G., S. Sheriff, Brett R. Beno, et al.. (2011). Investigation of the mode of binding of a novel series of N-benzyl-4-heteroaryl-1-(phenylsulfonyl)piperazine-2-carboxamides to the hepatitis C virus polymerase. Bioorganic & Medicinal Chemistry Letters. 21(8). 2212–2215. 8 indexed citations
13.
Zhou, Nannan, Fan Li, Hsu‐Tso Ho, et al.. (2010). Increased sensitivity of HIV variants selected by attachment inhibitors to broadly neutralizing antibodies. Virology. 402(2). 256–261. 16 indexed citations
14.
Wang, Tao, John F. Kadow, Zhongxing Zhang, et al.. (2009). Inhibitors of HIV-1 attachment. Part 4: A study of the effect of piperazine substitution patterns on antiviral potency in the context of indole-based derivatives. Bioorganic & Medicinal Chemistry Letters. 19(17). 5140–5145. 38 indexed citations
15.
Fink, Brian E., Gregory D. Vite, Harold Mastalerz, et al.. (2005). New dual inhibitors of EGFR and HER2 protein tyrosine kinases. Bioorganic & Medicinal Chemistry Letters. 15(21). 4774–4779. 37 indexed citations
16.
Walker, Michael, et al.. (2001). Synthesis of a novel C-10 spiro-epoxide of paclitaxel. Bioorganic & Medicinal Chemistry Letters. 11(13). 1683–1685. 4 indexed citations
17.
Chordia, Mahendra D., Haiqing Yuan, Prakash G. Jagtap, et al.. (2001). Synthesis and bioactivity of 2,4-diacyl analogues of paclitaxel. Bioorganic & Medicinal Chemistry. 9(1). 171–178. 12 indexed citations
18.
Wittman, Mark D., John F. Kadow, Dolatrai M. Vyas, et al.. (2001). Synthesis and antitumor activity of novel paclitaxel–chlorambucil hybrids. Bioorganic & Medicinal Chemistry Letters. 11(6). 811–814. 18 indexed citations
19.
Wittman, Mark D., Craig R. Fairchild, Kathy Johnston, et al.. (2001). Synthesis of metabolically blocked paclitaxel analogues. Bioorganic & Medicinal Chemistry Letters. 11(6). 809–810. 7 indexed citations
20.
Svensson, Håkan, John F. Kadow, Vivekananda M. Vrudhula, Philip M. Wallace, & Peter D. Senter. (1992). Monoclonal antibody-.beta.-lactamase conjugates for the activation of a cephalosporin mustard prodrug. Bioconjugate Chemistry. 3(2). 176–181. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vincent J. Kalish Breakdown of academic impact, for papers by Brian M. McKeever Breakdown of academic impact, for papers by M. Arshad Siddiqui Breakdown of academic impact, for papers by Naoyuki Kanzaki Breakdown of academic impact, for papers by Cristina Tintori Breakdown of academic impact, for papers by V. L. Narayanan Breakdown of academic impact, for papers by Marco Radi Breakdown of academic impact, for papers by Paul A. Aristoff Breakdown of academic impact, for papers by Antonio Coluccia Breakdown of academic impact, for papers by Robert Zahler
Rankless by CCL
2026